Nuclear Receptors in Myocardial and Cerebral Ischemia—Mechanisms of Action and Therapeutic Strategies
Nearly 18 million people died from cardiovascular diseases in 2019, of these 85% were due to heart attack and stroke. The available therapies although efficacious, have narrow therapeutic window and long list of contraindications. Therefore, there is still an urgent need to find novel molecular targ...
Guardado en:
Autores principales: | Joanna Rzemieniec, Laura Castiglioni, Paolo Gelosa, Majeda Muluhie, Benedetta Mercuriali, Luigi Sironi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/456adc5bcc2d44569d80c0c2bc32130f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PPARα Modulation-Based Therapy in Central Nervous System Diseases
por: Deokho Lee, et al.
Publicado: (2021) -
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
por: Kaleigh Katzer, et al.
Publicado: (2021) - PPAR research
-
Tryptophan Metabolism Activates Aryl Hydrocarbon Receptor-Mediated Pathway To Promote HIV-1 Infection and Reactivation
por: Yan-Heng Zhou, et al.
Publicado: (2019) -
Aryl Hydrocarbon Receptors in Indole Derivative Treated Mice: Neuropharmacological Perspectives
por: Andreeva-Gateva P., et al.
Publicado: (2021)